Pedro Zancanaro

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B

Deep Joshipura, Abdulaziz Alomran, Pedro Zancanaro et al. · Journal of the American Academy of Dermatology · 2018 · 75 citations · Full text

Translational Medicine, Medicine, Topical Drug +3

Sun-protective behaviors in patients with cutaneous hyperpigmentation: A cross-sectional study

Mayra B.C. Maymone, Hind H. Neamah, Stephen A. Wirya et al. · Journal of the American Academy of Dermatology · 2017 · 45 citations

Atopic Dermatitis, Clinical Dermatology, Wound Healing +3

Response to ustekinumab in three pediatric patients with alopecia areata

Abdullah Aleisa, Yeun Jina Lim, Samantha C. Gordon et al. · Pediatric Dermatology · 2018 · 39 citations

Dupilumab as a Treatment for Allergic Contact Dermatitis

Naina Chipalkatti, Nicole Lee, Pedro Zancanaro et al. · Dermatitis · 2018 · 36 citations

Rheumatology, Translational Medicine, Naina Bs +13

Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among patients visiting the emergency room at a tertiary hospital in Brazil

Julival Ribeiro, John M. Boyce, Pedro Zancanaro · The Brazilian Journal of Infectious Diseases · 2005 · 29 citations · Full text

Hospital Medicine, Healthcare-associated Infection, Clinical Epidemiology +16